Enzyme detects and kills anthrax

Rockefeller University researchers report potential defense and rapid-detection system.

Written byNicole Johnston
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Raymond Schuch and colleagues from Rockefeller University, New York, have identified an enzyme that kills Bacillus anthracis, and which can also be used to rapidly detect the presence of anthrax spores.

In the 22 August issue of Nature, Schuch et al. show that the bacteriolytic enzyme, PlyG lysin, protected a majority of mice infected with B. anthracis from dying. They also demonstrated that the enzyme can be used in a rapid-detection system that recognizes as few as 100 spores in a matter of minutes.

The Rockefeller group — led by microbiologist Vincent A. Fischetti — isolated the lysin from bacteriophage γ, a virus that specifically infects B. anthracis and is commonly used to identify the organism. Lysins are produced by double-stranded lytic phages and specifically target crucial carbohydrate targets in the cell wall of a particular bacterial species. During the phage lytic cycle, lysin is produced by the phage to ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Genome Modeling and Design: From the Molecular to Genome Scale

Genome Modeling and Design: From the Molecular to Genome Scale

Twist Bio 
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

DNA and pills, conceptual illustration of the relationship between genetics and therapeutic development

Multiplexing PCR Technologies for Biopharmaceutical Research

Thermo Fisher Logo
Discover how to streamline tumor-infiltrating lymphocyte production.

Producing Tumor-infiltrating Lymphocyte Therapeutics

cytiva logo

Products

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA

sartorius-logo

Introducing the iQue 5 HTS Platform: Empowering Scientists  with Unbeatable Speed and Flexibility for High Throughput Screening by Cytometry

parse_logo

Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella

shiftbioscience

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery